Bridging Science & New Therapeutics for HDV Elimination

Bridging Science & New Therapeutics for HDV Elimination

February 1 2022
09:00 AM
Bridging Science and New Therapeutics

Join the Coalition for Global Hepatitis Elimination and ICE-HBV for this webinar on February 1st to dive into the current state of hepatitis D (HDV) elimination. As the world continues to make progress against hepatitis B and hepatitis C, additional research must prioritize estimates of the burden of HDV, improving the quality of HDV diagnostics and therapeutics, and expanding access to HDV screening and treatment.


Program


From Discovery to Current Challenges | Mario Rizzetto, Department of Medical Sciences, University of Turin, Italy

Virology and Diagnostic Needs | Dieter Glebe, Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, Justus Liebig University Giessen, Germany; German Center for Infection Research, Germany (DZIF)

Epidemiology and Clinical Features | Pietro Lampertico, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; CRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Italy

Innovation in Therapy | Marc Bourliere, Department of Hepatology and Gastroenterology, Hôpital Saint-Joseph, France; INSERM UMR1252 IRD SESSTIM sciences économiques et sociales de la santé & traitement de l’information médicale Aix Marseille Université, France

To be followed by a Roundtable Discussion

Email the Coalition for Global Hepatitis Elimination at globalhep [at] taskforce.org.